Investing.com - Joincare Pharm reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Joincare Pharm announced earnings per share of ¥0.17 on revenue of ¥4.45. Analysts polled by Investing.com anticipated EPS of ¥0.19 on revenue of ¥17,535M.
Joincare Pharm shares are down 11.7% from the beginning of the year and are trading at ¥12.02 , down-from-52-week-high.
Joincare Pharm shares gained 1.01% in intra-day trade the report.
Joincare Pharm follows other major Healthcare sector earnings this month
Joincare Pharm's report follows an earnings missed by Aier Eye Hospital Group on Wednesday, who reported EPS of ¥0.15 on revenue of ¥4.94B, compared to forecasts EPS of ¥0.1722 on revenue of ¥5.7B.
Imeik had missed expectations on Wednesday with third quarter EPS of ¥1.85 on revenue of ¥604.5M, compared to forecast for EPS of ¥1.95 on revenue of ¥692.11M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar